When searching for a “5127 round white pill,” the query most commonly results from a slight misreading of the imprint on one of two distinct pharmaceutical tablets, or refers to a specific strength within standardized generic imprint lines:
- Primary Match (Most Common): The
512pill — a white, round tablet containing Oxycodone Hydrochloride (5 mg) and Acetaminophen (325 mg) manufactured by Mallinckrodt Pharmaceuticals. The score line or slight debossing artifacts often lead users to read the marking as5127or512 / 7. - Alternative Match: Famciclovir 125 mg (imprinted with
54 127, white, round) or generic Benazepril 40 mg (imprinted93 5127, though typically pink and three-sided).
Given the significant clinical and safety implications, the full pharmacological profile below covers the primary match: Oxycodone Hydrochloride 5 mg / Acetaminophen 325 mg (imprint 512 / 5127).
Pill Identification & Physical Characteristics
Property – Primary Match (Oxycodone / APAP 5/325) | Secondary Match (Famciclovir 125 mg)
- Active Ingredients – Oxycodone HCl (5 mg) & Acetaminophen (325 mg) – Famciclovir (125 mg)
- Imprint –
512on one side (scored on reverse) –54 127on one side - Shape & Color – Round; White | Round; White
- Drug Class – Schedule II Opioid / Non-Opioid Combination – Antiviral (Guanine Analogue)
- Manufacturer – Mallinckrodt Pharmaceuticals – Hikma / Roxane Laboratories
Mechanism of Action
The combination tablet exerts dual-action analgesia by modulating both central opioid pathways and non-opioid pain/temperature regulatory mechanisms:
- Oxycodone Component (Opioid Receptor Agonist):
- Selectively binds to opioid receptors distributed throughout the central nervous system (CNS) and peripheral tissues.
- Inhibits the presynaptic release of excitatory nociceptive neurotransmitters (such as glutamate and substance P) and hyperpolarizes postsynaptic neurons by opening potassium channels.
- Stimulates descending inhibitory pathways and alters the affective perception of pain within the limbic system, producing analgesia and euphoria.
- Acetaminophen Component (APAP):
- Acts primarily in the CNS by inhibiting prostaglandin synthesis through central peroxidase-mediated cyclooxygenase (COX) inhibition.
- Modulates descending serotonergic bulbospinal pathways and indirectly activates the cannabinoid system via its active metabolite AM404.
- Resets hypothalamic thermoregulatory centers to produce antipyresis (fever reduction) without inducing peripheral anti-inflammatory or antiplatelet effects.
Indications & Dosage
Approved Indications
- Relief of moderate to severe acute pain where non-opioid options are inadequate, contraindicated, or ineffective (e.g., post-operative recovery, acute orthopedic trauma, dental surgery).
General Adult Dosing
- Standard Dose: 1 tablet orally every 4 to 6 hours as needed for acute pain.
- Maximum Daily Thresholds:
- Acetaminophen Ceiling: Total daily intake from all sources (prescription and OTC) must not exceed 4,000 mg in 24 hours (maximum 8 tablets daily) to prevent irreversible hepatotoxicity. Clinical practice often aims for a lower ceiling.
- Shortest Effective Duration: Therapy should be limited to the lowest effective dose for the minimum duration required (typically 3 to 7 days for acute, non-chronic conditions).
- Administration: Swallow whole with a full glass of water. May be taken with food or milk to minimize gastrointestinal irritation.
Side Effects
Common Adverse Reactions
- Drowsiness, lightheadedness, dizziness, and sedation
- Nausea, vomiting, and abdominal cramping
- Constipation (prophylactic bowel management is often recommended)
- Dry mouth (xerostomia), diaphoresis (sweating), and pruritus (itching)
Severe & Emergent Adverse Reactions
- Life-Threatening Respiratory Depression: Critically slow, shallow, or irregular breathing leading to respiratory arrest.
- Acute Hepatotoxicity: Severe liver injury or acute liver failure caused by excessive acetaminophen consumption.
- Severe Hypotension & Bradycardia: Profound drop in blood pressure and syncope (fainting).
- Adrenal Insufficiency: Suppressed hypothalamic-pituitary-adrenal (HPA) axis function with chronic opioid use.
- Severe Skin Reactions: Rare, life-threatening cutaneous reactions from acetaminophen (e.g., Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis).
Precautions & Drug Interactions
- CNS Depressants and Benzodiazepines: Concomitant use with benzodiazepines, sedatives, muscle relaxants, hypnotics, or alcohol causes synergistic central nervous system depression, dramatically increasing the risk of coma, respiratory arrest, and death.
- Overlapping Acetaminophen: Strict avoidance of concurrent over-the-counter cough/cold syrups, sinus remedies, or other prescription painkillers containing acetaminophen to avoid accidental toxic accumulation.
- CYP3A4 and CYP2D6 Inhibitors/Inducers: Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) increase oxycodone systemic exposure, while inducers (e.g., rifampin, carbamazepine) decrease analgesic efficacy or precipitate withdrawal.
- Respiratory Compromise: Contraindicated in patients with significant respiratory depression, acute or severe bronchial asthma in unmonitored settings, and known or suspected gastrointestinal obstruction, including paralytic ileus.
- Pregnancy & Nursing: Prolonged maternal use during pregnancy can cause Neonatal Opioid Withdrawal Syndrome (NOWS).
Black Box Warnings
- FDA Boxed Warnings:
- Addiction, Abuse, and Misuse: Carries high potential for opioid use disorder, diversion, overdose, and death.
- Life-Threatening Respiratory Depression: Severe, life-threatening, or fatal respiratory depression may occur, particularly at therapy initiation or following dose escalation.
- Hepatotoxicity: Acetaminophen is a leading cause of acute liver failure, sometimes requiring liver transplantation or resulting in death.
- Risks from Concomitant Use with Benzodiazepines or Alcohol: Concurrent use can lead to profound sedation, respiratory failure, coma, and fatal overdose.
- Accidental Pediatric Ingestion: Accidental ingestion of even a single dose, especially by children, can result in fatal opioid toxicity.
- Opioid Overdose Reversal: Education on and co-prescription of naloxone for emergency treatment of opioid overdose is strongly advised.